insights_auto
Varför har ALNOV gått ned 3,44%?
Gå på djupetchevron_right
ALNOV:EPA
Novacyt SA
0,43 €
arrow_downward
−3,44%(−0,015) 1 d
17 nov., 15:33:45 GMT+1 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för ALNOV …
Öppen
0,45 €
Högt
0,45 €
Lågt
0,43 €
Börsvärde
31,53 mn
Genomsn. vol.
168,29 tn
Volym
8,17 tn
52v högst
1,04 €
52v lägst
0,29 €
EPS
−0,38 €
Utestående aktier
72,59 mn
Antal anställda
228
Öppen
0,45 €
Högt
0,45 €
Lågt
0,43 €
Börsvärde
31,53 mn
Genomsn. vol.
168,29 tn
Volym
8,17 tn
52v högst
1,04 €
52v lägst
0,29 €
EPS
−0,38 €
Utestående aktier
72,59 mn
Antal anställda
228
Nyheter och artiklar
Från webbkällor och nyhetspartner
TradingView
·
för 2 timmar sedan
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
för 1 timme sedan
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
för 52 minuter sedan
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
Traders Union
·
för 1 timme sedan
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Om Novacyt SA
VdDavid Allmond
Anställda228
Grundades3 juli 2006
Huvudkontor-
SektorHealth Care
Bransch-
Webbplatsnovacyt.com